-
Efficacy and safety of rosuvastatin vs. atorvastatin in lowering LDL cholesterol : A meta-analysis of trials with East Asian populationsZhang L, Zhang S, Ge J et al. -
Genetic dysregulation of endothelin-1 is implicated in coronary microvascular dysfunctionTJ Ford, D Corcoran, S Padmanabhan et al.
-
A VOYAGER Meta-Analysis of the Impact of Statin Therapy on Low-Density Lipoprotein Cholesterol and Triglyceride Levels in Patients With HypertriglyceridemiaKarlson BW, Palmer MK, Nicholls SJ et al.
-
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-upB Bikdeli, MV Madhavan, D Jimenez et al.
-
2-Year Outcomes After Stenting of Lipid-Rich and Nonrich Coronary PlaquesMHwa Yamamoto, A Maehara, GW Stone et al.
-
Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart AssociationCB Newman and and on behalf of the American Heart Association Clinical Lipidology, Lipoprotein, Metabolism and Thrombosis Committee, a Joint Committee of the Council on Atherosclerosis, Thrombosis and Vascular Biology and Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Clinical Cardiology; and Stroke Council.
-
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice GuidelinesStone NJ, Robinson JG, American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
-
Clinician’s Guide to Reducing Inflammation to Reduce Atherothrombotic RiskPM Ridker
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
